Literature DB >> 21468214

Lantibiotics as prospective antimycobacterial agents.

John Donaghy1.   

Abstract

Keywords:  antimycobacterial; bacteriocins; lantibiotics; mycobacteria; resistant

Mesh:

Substances:

Year:  2010        PMID: 21468214      PMCID: PMC3056097          DOI: 10.4161/bbug.1.6.13855

Source DB:  PubMed          Journal:  Bioeng Bugs        ISSN: 1949-1018


× No keyword cloud information.
  10 in total

Review 1.  Bacterial lantibiotics: strategies to improve therapeutic potential.

Authors:  Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Curr Protein Pept Sci       Date:  2005-02       Impact factor: 3.272

Review 2.  Genetically engineered bacteriocins and their potential as the next generation of antimicrobials.

Authors:  Osnat Gillor; Lisa M Nigro; Margaret A Riley
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 3.  Mycobacterium tuberculosis: drug resistance and future perspectives.

Authors:  Giovanna Riccardi; Maria Rosalia Pasca; Silvia Buroni
Journal:  Future Microbiol       Date:  2009-06       Impact factor: 3.165

Review 4.  Mycobacteria in drinking water distribution systems: ecology and significance for human health.

Authors:  Mario J M Vaerewijck; Geert Huys; Juan Carlos Palomino; Jean Swings; Françoise Portaels
Journal:  FEMS Microbiol Rev       Date:  2005-02-19       Impact factor: 16.408

5.  Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.

Authors:  James Carroll; Lorraine A Draper; Paula M O'Connor; Aidan Coffey; Colin Hill; R Paul Ross; Paul D Cotter; Jim O'Mahony
Journal:  Int J Antimicrob Agents       Date:  2010-05-23       Impact factor: 5.283

6.  Nisin A depletes intracellular ATP and acts in bactericidal manner against Mycobacterium smegmatis.

Authors:  T J Montville; H J Chung; M L Chikindas; Y Chen
Journal:  Lett Appl Microbiol       Date:  1999-03       Impact factor: 2.858

Review 7.  Extensively drug-resistant tuberculosis: current challenges and threats.

Authors:  Amita Jain; Rajesh Mondal
Journal:  FEMS Immunol Med Microbiol       Date:  2008-05-08

Review 8.  Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.

Authors:  A Parisien; B Allain; J Zhang; R Mandeville; C Q Lan
Journal:  J Appl Microbiol       Date:  2008-01       Impact factor: 3.772

Review 9.  Lantibiotics: peptides of diverse structure and function.

Authors:  Joanne M Willey; Wilfred A van der Donk
Journal:  Annu Rev Microbiol       Date:  2007       Impact factor: 15.500

10.  Antimycobacterial activity of bacteriocins and their complexes with liposomes.

Authors:  Vasily Sosunov; Vladimir Mischenko; Boris Eruslanov; Edward Svetoch; Yulia Shakina; Norman Stern; Konstantin Majorov; Galina Sorokoumova; Alla Selishcheva; Alexander Apt
Journal:  J Antimicrob Chemother       Date:  2007-03-08       Impact factor: 5.790

  10 in total
  3 in total

1.  Overexpression, purification, crystallization and preliminary X-ray diffraction of the nisin resistance protein from Streptococcus agalactiae.

Authors:  Sakshi Khosa; Astrid Hoeppner; Diana Kleinschrodt; Sander H J Smits
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-05-20       Impact factor: 1.056

2.  Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent.

Authors:  Henok Asfaw; Katja Laqua; Anna Maria Walkowska; Fraser Cunningham; Maria Santos Martinez-Martinez; Juan Carlos Cuevas-Zurita; Lluís Ballell-Pages; Peter Imming
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

3.  Lactic acid Bacteria isolated from European badgers (Meles meles) reduce the viability and survival of Bacillus Calmette-Guerin (BCG) vaccine and influence the immune response to BCG in a human macrophage model.

Authors:  Anna Stedman; Carlos Maluquer de Motes; Sandrine Lesellier; Deanna Dalley; Mark Chambers; Jorge Gutierrez-Merino
Journal:  BMC Microbiol       Date:  2018-07-13       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.